Subtype and regional-specific neuroinflammation in sporadic creutzfeldt-jakob disease

Frontiers in Aging Neuroscience

Volumn 6, Issue JUL, 2014, Pages

  Llorens, Franc ^a,b   Lopez Gonzalez, Irene ^b   Thune, Katrin ^a   Carmona, Margarita ^b,c   Zafar, Saima ^a   Andeoletti, Olivier ^d   Zerr, Inga ^a   Ferrer, Isidre ^b,c  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

Creutzfeldt Jakob disease; Cytokines; Microglia; Neuroinflammation; Prion protein

Indexed keywords

CATHEPSIN; CD11B ANTIGEN; CHLORDANE; COLONY STIMULATING FACTOR; COLONY STIMULATING FACTOR 1; COPPER ZINC SUPEROXIDE DISMUTASE; CYCLOOXYGENASE 2; CYTOKINE; GLIAL FIBRILLARY ACIDIC PROTEIN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTEGRIN; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; INTERLEUKIN 10 RECEPTOR ALPHA; INTERLEUKIN 10 RECEPTOR BETA; INTERLEUKIN 17 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 8; JANUS KINASE; OLIGODENDROCYTE TRANSCRIPTION FACTOR 2; STAT PROTEIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TRANSCRIPTION FACTOR RELA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; BETA ACTIN; CATHEPSIN S; CD68 ANTIGEN; DIPEPTIDYL PEPTIDASE I; I KAPPA B KINASE; INTERLEUKIN 1BETA; MESSENGER RNA; STAT1 PROTEIN; STAT3 PROTEIN; TUMOR NECROSIS FACTOR;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; ASTROCYTOSIS; BRAIN; BRAIN CORTEX; BRAIN STEM; CELL ISOLATION; CELL LYSATE; CELL SPECIFICITY; CELLULAR DISTRIBUTION; CEREBELLUM; COMPLEMENT SYSTEM; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE COURSE; ENTORHINAL CORTEX; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; FRONTAL CORTEX; GENE EXPRESSION; GLIA CELL; GLOMERULUS; HIPPOCAMPUS; HUMAN; IMMUNE RESPONSE; IMMUNOREACTIVITY; INFLAMMATION; MICROGLIA; MOUSE; NERVE CELL; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PURKINJE CELL; REGIONAL SPECIFIC NEUROINFLAMMATION; SIGNAL TRANSDUCTION; SPECIES DIFFERENCE; SPORADIC CREUTZFELDT JAKOB DISEASE; SUBTYPE NEUROINFLAMMATION; THALAMUS; UPREGULATION; WESTERN BLOTTING; WHITE MATTER; ANIMAL TISSUE; BRAIN NERVE CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 84904708100     PISSN: None     EISSN: 16634365     Source Type: Journal    
DOI: 10.3389/fnagi.2014.00198     Document Type: Article

References (59)

1. Aguzzi A, Barres BA, Bennett ML. Microglia: scapegoat, saboteur, or something else? Science 2013; 339: 156-161.
2. Akhtar S, Grizenkova J, Wenborn A et al. Sod1 deficiency reduces incubation time in mouse models of prion disease. PLoS One 2013; 8: e54454.
3. Anisman H, Merali Z, Hayley S. Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: comorbidity between depression and neurodegenerative disorders. Prog Neurobiol 2008; 85: 1-74.
4. Ansoleaga B, Garcia-Esparcia P, Llorens F, Moreno J, Aso E, Ferrer I. Dysregulation of brain olfactory and taste receptors in AD, PSP and CJD, and AD-related model. Neuroscience 2013; 248C: 369-382.
5. Appleby BS, Appleby KK, Crain BJ, Onyike CU, Wallin MT, Rabins PV. Characteristics of established and proposed sporadic Creutzfeldt-Jakob disease variants. Arch Neurol 2009; 66: 208-215.
6. Asuni AA, Gray B, Bailey J, Skipp P, Perry VH, O'Connor V. Analysis of the Hippocampal Proteome in ME7 Prion Disease Reveals a Predominant Astrocytic Signature and Highlights the Brain-restricted Production of Clusterin in Chronic Neurodegeneration. J Biol Chem 2014; 289: 4532-4545.
7. Block ML, Zecca L, Hong JS. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 2007; 8: 57-69.
8. Bonifati DM, Kishore U. Role of complement in neurodegeneration and neuroinflammation. Mol Immunol 2007; 44: 999-1010.
9. Brown AR, Webb J, Rebus S, Walker R, Williams A, Fazakerley JK. Inducible cytokine gene expression in the brain in the ME7/CV mouse model of scrapie is highly restricted, is at a strikingly low level relative to the degree of gliosis and occurs only late in disease. J Gen Virol 2003; 84: 2605-2611.
10. Campbell IL, Eddleston M, Kemper P, Oldstone MB, Hobbs MV. Activation of cerebral cytokine gene expression and its correlation with onset of reactive astrocyte and acute-phase response gene expression in scrapie. J Virol 1994; 68: 2383-2387.
11. Cheng B, Christakos S, Mattson MP. Tumor necrosis factors protect neurons against metabolicexcitotoxic insults and promote maintenance of calcium homeostasis. Neuron 1994; 12:139-153.
12. Colby DW, Prusiner SB. Prions. Cold Spring Harb Perspect Biol 2011; 3: a006833
13. Cunningham C, Deacon R, Wells H et al. Synaptic changes characterize early behavioural signs in the ME7 model of murine prion disease. Eur J Neurosci 2003; 17: 2147-2155.
14. Deininger MH, Bekure-Nemariam K, Trautmann K, Morgalla M, Meyermann R, Schluesener HJ. Cyclooxygenase-1 and -2 in brains of patients who died with sporadic Creutzfeldt-Jakob disease. J Mol Neurosci 2003; 20: 25-30.
15. Falsig J, Julius C, Margalith I, Schwarz P, Heppner FL, Aguzzi A. A versatile prion replication assay in organotypic brain slices. Nat Neurosci 2008; 11: 109-117.
16. Frankola KA, Greig NH, Luo W, Tweedie D. Targeting TNF-alpha to elucidate and ameliorate neuroinflammation in neurodegenerative diseases. CNS Neurol Disord Drug Targets 2011; 10: 391-403.
17. Freixes M, Puig B, Rodriguez A, Torrejon-Escribano B, Blanco R, Ferrer I. Clusterin solubility and aggregation in Creutzfeldt-Jakob disease. Acta Neuropathol 2004; 108: 295-301.
18. Giese A, Brown DR, Groschup MH, Feldmann C, Haist I, Kretzschmar HA. Role of microglia in neuronal cell death in prion disease. Brain Pathol 1998; 8: 449-457.
19. Gomez-Nicola D, Fransen NL, Suzzi S, Perry VH. Regulation of microglial proliferation during chronic neurodegeneration. J Neurosci 2013; 33: 2481-2493.
20. Greten FR, Arkan MC, Bollrath J et al. NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta. Cell 2007; 130: 918-931.
21. Griffin WS. Inflammation and neurodegenerative diseases. Am J Clin Nutr 2006; 83: 470S-474S
22. Guiroy DC, Wakayama I, Liberski PP, Gajdusek DC. Relationship of microglia and scrapie amyloidimmunoreactive plaques in kuru, Creutzfeldt-Jakob disease and Gerstmann-Straussler syndrome. Acta Neuropathol 1994; 87: 526-530.
23. Hughes MM, Field RH, Perry VH, Murray CL, Cunningham C. Microglia in the degenerating brain are capable of phagocytosis of beads and of apoptotic cells, but do not efficiently remove PrPSc, even upon LPS stimulation. Glia 2010; 58: 2017-2030.
24. Julius C, Heikenwalder M, Schwarz P et al. Prion propagation in mice lacking central nervous system NF-kappaB signalling. J Gen Virol 2008; 89: 1545-1550.
25. Kim JI, Ju WK, Choi JH et al. Expression of cytokine genes and increased nuclear factor-kappa B activity in the brains of scrapie-infected mice. Brain Res Mol Brain Res 1999; 73: 17-27.
26. Kisseleva T, Bhattacharya S, Braunstein J, Schindler CW. Signaling through the JAK/STAT pathway, recent advances and future challenges. Gene 2002; 285: 1-24.
27. Kovacs GG, Budka H. Distribution of apoptosis-related proteins in sporadic Creutzfeldt-Jakob disease. Brain Res 2010; 1323: 192-199.
28. Liberski PP, Ironside JW. An outline of the neuropathology of transmissible spongiform encephalopathies (prion diseases). Folia Neuropathol 2004; 42 Suppl B: 39-58.
29. Llorens F, Ansoleaga B, Garcia-Esparcia P et al. PrP mRNA and protein expression in brain and PrP(c) in CSF in Creutzfeldt-Jakob disease MM1 and VV2. Prion 2013; 7: 383-393.
30. Mabbott NA, Bruce ME, Botto M, Walport MJ, Pepys MB. Temporary depletion of complement component C3 or genetic deficiency of C1q significantly delays onset of scrapie. Nat Med 2001; 7: 485-487.
31. Mattson MP, Camandola S. NF-kappaB in neuronal plasticity and neurodegenerative disorders. J Clin Invest 2001; 107:247-254.
32. Minghetti L, Pocchiari M. Cyclooxygenase-2, prostaglandin E2, and microglial activation in prion diseases. Int Rev Neurobiol 2007; 82: 265-275.
33. Muhleisen H, Gehrmann J, Meyermann R. Reactive microglia in Creutzfeldt-Jakob disease. Neuropathol Appl Neurobiol 1995; 21: 505-517.
34. Na YJ, Jin JK, Kim JI, Choi EK, Carp RI, Kim YS. JAK-STAT signaling pathway mediates astrogliosis in brains of scrapie-infected mice. J Neurochem 2007; 103: 637-649.
35. Oumata N, Nguyen PH, Beringue V et al. The toll-like receptor agonist imiquimod is active against prions. PLoS One 2013; 8: e72112.
36. Padilla D, Beringue V, Espinosa JC et al. Sheep and goat BSE propagate more efficiently than cattle BSE in human PrP transgenic mice. PLoS Pathog 2011; 7: e1001319.
37. Parchi P, de BL, Saverioni D et al. Consensus classification of human prion disease histotypes allows reliable identification of molecular subtypes: an inter-rater study among surveillance centres in Europe and USA. Acta Neuropathol 2012; 124: 517-529.
38. Parchi P, Giese A, Capellari S et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999; 46: 224-233.
39. Parchi P, Strammiello R, Notari S et al. Incidence and spectrum of sporadic Creutzfeldt-Jakob disease variants with mixed phenotype and co-occurrence of PrPSc types: an updated classification. Acta Neuropathol 2009; 118: 659-671.
40. Pasquali P, Nonno R, Mandara MT et al. Intracerebral administration of interleukin-12 (IL-12) and IL 18 modifies the course of mouse scrapie. BMC Vet Res 2006; 2: 37.
41. Prinz M, Heikenwalder M, Schwarz P, Takeda K, Akira S, Aguzzi A. Priori pathogenesis in the absence of Toll-like receptor signalling. EMBO Rep 2003; 4: 195-199.
42. Rajan P, McKay RD. Multiple routes to astrocytic differentiation in the CNS. J Neurosci 1998; 18: 3620-3629.
43. Sasaki A, Hirato J, Nakazato Y. Immunohistochemical study of microglia in the Creutzfeldt-Jakob diseased brain. Acta Neuropathol 1993; 86: 337-344.
44. Sasaki K, Doh-ura K, Ironside JW, Iwaki T. Increased clusterin (apolipoprotein J) expression in human and mouse brains infected with transmissible spongiform encephalopathies. Acta Neuropathol 2002; 103: 199-208.
45. Schindler CW. Series introduction. JAK-STAT signaling in human disease. J Clin Invest 2002; 109: 1133-1137.
46. Schultz J, Schwarz A, Neidhold S et al. Role of interleukin-1 in prion disease-associated astrocyte activation. Am J Pathol 2004; 165: 671-678.
47. Schulz-Schaeffer WJ, Fatzer R, Vandevelde M, Kretzschmar HA. Detection of PrP(Sc) in subclinical BSE with the paraffin-embedded tissue (PET) blot. Arch Virol Suppl 2000; 173-180.
48. Sharief MK, Green A, Dick JP, Gawler J, Thompson EJ. Heightened intrathecal release of proinflammatory cytokines in Creutzfeldt-Jakob disease. Neurology 1999; 52: 1289-1291.
49. Shi Q, Xie WL, Zhang B et al. Brain microglia were activated in sporadic CD but almost unchanged in fatal familial insomnia and G114V genetic CJD. Virol J 2013; 10: 216.
50. Shishodia S, Koul D, Aggarwal BB. Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates TNF-induced NF-kappa B activation through inhibition of activation of I kappa B alpha kinase and Akt in human non-small cell lung carcinoma: correlation with suppression of COX-2 synthesis. J Immunol 2004; 173: 2011-2022.
51. Spinner DS, Cho IS, Park SY et al. Accelerated prion disease pathogenesis in Toll-like receptor 4 signaling-mutant mice. J Virol 2008; 82: 10701-10708.
52. Stoeck K, Bodemer M, Zerr I. Pro- and anti-inflammatory cytokines in the CSF of patients with Creutzfeldt-Jakob disease. J Neuroimmunol 2006; 172: 175-181.
53. Szpak GM, Lewandowska E, Lechowicz W et al. The brain immune response in human prion diseases. Microglial activation and microglial disease. I. Sporadic Creutzfeldt-Jakob disease. Folia Neuropathol 2006; 44: 202-213.
54. Tamguney G, Giles K, Glidden DV et al. Genes contributing to prion pathogenesis. J Gen Virol 2008; 89: 1777-1788.
55. Thackray AM, McKenzie AN, Klein MA, Lauder A, Bujdoso R. Accelerated prion disease in the absence of interleukin-10. J Virol 2004; 78: 13697-13707.
56. Tribouillard-Tanvier D, Striebel JF, Peterson KE, Chesebro B. Analysis of protein levels of 24 cytokines in scrapie agent-infected brain and glial cell cultures from mice differing in prion protein expression levels. J Virol 2009; 83: 11244-11253.
57. Van EB, Dewulf E, Pals P, Lubke U, Martin JJ, Cras P. The role of cytokines, astrocytes, microglia and apoptosis in Creutzfeldt-Jakob disease. Neurobiol Aging 2002; 23: 59-64.
58. Walsh DT, Betmouni S, Perry VH. Absence of detectable IL-1beta production in murine prion disease: a model of chronic neurodegeneration. J Neuropathol Exp Neurol 2001; 60: 173-182.
59. Williams A, Lucassen PJ, Ritchie D, Bruce M. PrP deposition, microglial activation, and neuronal apoptosis in murine scrapie. Exp Neurol 1997; 144: 433-438.